
We are pleased to inform you about the launch of our new multiplex Real-time PCR assay for the detection of the monkeypox virus and its differentiation from other orthopox viruses. This product complements Gold Standard Diagnostics Europe's suite of assays developed in response to infectious diseases, such as the GSD NovaPrime and NovaType assay families, developed for SARS-CoV-2 detection and variant identification.
Since the start of the monkeypox outbreak, the number of confirmed cases has risen to over 7.000 in more than 50 countries [1]. With this kit, we hope to help in the fight against this rare disease.
If you are interested in this assay and wish to receive the Instructions for Use, please contact your sales representative.
We are looking forward to hearing back from you.
Gold Standard Diagnostics Europe
marketing@goldstandarddiagnostics.eu
Reference
[1] https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html